Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Porter

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Anticancer Research|May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studiesL Li, Z Zhu, B Joshi, et al.
Urology|August 1, 1995
Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancerX Gao, D J Grignon, T Chbihi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancerA T Porter, A J McEwan, J E Powe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610A Pollack, D J Grignon, K H Heydon, et al.
The Prostate|February 11, 1999
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosisS V Garde, V S Basrur, L Li, et al.
Pathology Oncology Research : POR|October 8, 1998
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteasesD G Tang, L Li, Z Zhu, et al.
Pathology Oncology Research : POR|March 1, 1996
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterationsK V Honn, A Aref, Y Q Chen, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutrontherapy facilitiesJ Gueulette, M Beauduin, V Grégoire, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Anticancer Research|May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studiesL Li, Z Zhu, B Joshi, et al.
Urology|August 1, 1995
Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancerX Gao, D J Grignon, T Chbihi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancerA T Porter, A J McEwan, J E Powe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610A Pollack, D J Grignon, K H Heydon, et al.
The Prostate|February 11, 1999
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosisS V Garde, V S Basrur, L Li, et al.
Pathology Oncology Research : POR|October 8, 1998
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteasesD G Tang, L Li, Z Zhu, et al.
Pathology Oncology Research : POR|March 1, 1996
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterationsK V Honn, A Aref, Y Q Chen, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutrontherapy facilitiesJ Gueulette, M Beauduin, V Grégoire, et al.
Pageof 12